- 10 federal government, policy updates for dentists to know
- The highest-paid ophthalmologist in the 10 largest Northeastern cities
- Arizona cardiology group pays $4.75M to settle false claims allegations
- Why AI is keeping dental practice owners up at night
- OSF HealthCare uses text outreach after ED visits — and sees 33% engagement
- Drug affordability worries highest since 2018: KFF poll
- Eliquis may be safer than Xarelto for patients with deep blood clots: Study
- Medicare spending on ASCs jumps 16% in 1 year: MedPAC
- 47 recent hospital, health system executive moves
- Lawmakers scrutinize payers: What it means for healthcare providers
- The uneven competition in physician markets
- ‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
- Judge grants Mississippi hospital pause on Medicaid debt repayment
- Judge grants Mississippi hospital pause on Medicaid debt repayment
- Inside the erosion of independence in cardiology
- OIG green-lights ASC cataract supply discount proposal
- Arkansas regional hospital taps chief medical officer
- Tampa General hospital 2nd in the world to get women’s surgery designation
- Nurses plan strike at Northern Light Eastern Maine
- Children’s Hospital of Philadelphia anesthesiologist receives lifetime achievement award
- MUSC Health names hospital CEO
- Oceans Behavioral Hospital debuts virtual outpatient program
- With $50B rural health fund, 23rd state joins PA licensure compact
- UF Health opens 24K-square-foot orthopedic surgical center
- Illinois health association to open $4M dental practice
- Medtronic inks ASC deal with Access GPO
- 30+ dental industry updates in California, Florida and Texas
- North Carolina weighs bill to cut facility fees for hospital-owned clinics
- Heartland Dental expands in 4 states
- Crestwood Behavioral Health names program chief
- Dartmouth hospital launches social work department
- Georgia health system launches new digital patient billing system
- 5 DSOs making headlines
- Oceans behavioral health hospital taps CEO
- Pediatric dental, orthodontic practice building sold for $4.4M
- San Francisco secures $100M to expand behavioral health treatment to 3 sites
- How nursing backgrounds shaped 2 revenue cycle leaders
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Bad News for Multitaskers: Your Brain Can’t Really Do It
- OSF HealthCare uses digital therapeutics to create a digital path to care
- Former Tenet CFO joins Acadia Healthcare board
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- Microsoft Unveils AI Health Tool That Can Read Your Medical Records
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- The feds will overpay Medicare Advantage plans by $76B this year, MedPAC estimates
- FDA Launches New Adverse Event Look-Up Tool
- FDA Launches New Adverse Event Look-Up Tool
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- Bayer found to have discredited pharma industry after Roche row
- Industry Voices—Fast answers, fragile data: the trust problem in AI-driven healthcare analytics
- Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
- GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy
- Experts Weigh in on Digital Health Wearables for Neurological Health
- Ultra-Processed Foods Bad For Bone Health, Researchers Say
- AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Fertility Treatments Aren't Linked To Added Cancer Risk For Women, Study Concludes
- There's One Simple Way Cancer Patients Can Ward Off 'Chemo Brain,' Study Finds
- Younger Stroke Survivors Face Unique Mental Health Hurdles
- 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success
- Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
- Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
- Doctors Warn of a Deadly Complication From Measles Outbreaks
- FDA scolds CDMO Simtra with warning letter over contamination fumbles
- FDA fires off another manufacturing-related CRL, this one to Hyloris
- Hospital margins take a dive
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- Healthcare worker burnout, anxiety widespread, GAO finds
- Utah passes bill expanding hygienists’ ability to practice without dentist supervision
- Medicare Advantage spending 14% higher than fee for service: Report
- Virginia weighs spending cap on Medicaid dental services to resolve budget shortfall: 5 notes
- Washington hospital to close pediatric rehab clinic
- New Jersey system partners with health center ahead of ED closure
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Dana-Farber boosts operating margin to 8.4% in Q1
- Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall
- Oregon lawmakers greenlight $44M lifeline for hospital
- Florida Senate vote dissolves hospital board
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- At HIMSS26, Dr. Oz, CMS officials push agentic AI adoption. Are Medicare beneficiaries ready?
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Genetic Test May Predict Leukemia Relapse Risk
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- Microsoft unveils Copilot Health as an AI health companion for consumers
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Patent expirations push biopharma industry toward a tougher 2026
- Bancos, primera línea de batalla contra los fraudes financieros a adultos mayores
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- NYU Stern report calls for private equity reforms to safeguard quality of care
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Chile Becomes First Country in the Americas To Eliminate Leprosy
Barry Cadden, the former President of New England Compounding Center (NECC), was given a 10- to 15-year sentence by Judge Matthew McGivney, the Chief Judge for the 44th Circuit Court in Livingston County, Michigan:
Pharmacy exec sentenced in Michigan over deadly 2012 meningitis outbreak
By Nate Raymond - May 10, 2024May 10 (Reuters) - A former owner of a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly U.S. fungal meningitis outbreak in 2012 was sentenced on Friday to at least 10 years in prison for his role in the deaths of 11 Michigan residents.
Barry Cadden, the former president of New England Compounding Center (NECC), was sentenced by Judge Matthew McGivney in Howell, Michigan, after pleading no contest in March to involuntary manslaughter charges related to the 11 deaths.
The 10- to 15-year sentence will run concurrently with an already-imposed 14-1/2 year federal prison term that Cadden, 57, is serving after he was convicted in 2017 on racketeering and fraud charges related to misrepresentations he made to NECC customers about its drugs.
Federal prosecutors in Boston had also sought to convict Cadden of second-degree murder over 25 deaths nationally caused by mold-tainted steroids that Framingham, Massachusetts-based NECC produced. Jurors acquitted Cadden of those charges.
Michigan's attorney general subsequently brought charges in state court against Cadden and Glenn Chin, NECC's former supervisory pharmacist, who like Cadden was convicted of federal fraud charges but cleared at trial of second-degree murder.
"The families of these 11 victims will forever bear the weight of Mr. Cadden's greed and disregard for basic standards that caused this horrific tragedy," Michigan Attorney General Dana Nessel said in a statement.
Prosecutors said NECC produced the drugs in filthy and unsafe conditions and sold them to hospitals and clinics nationally. The outbreak sickened 793 patients, more than 100 of whom have died, federal prosecutors have said.
Cadden's sentence on Friday credited him for the more than 6-1/2 years he has already spent in custody, according to his lawyer, Gerald Gleeson. He had no further comment.
Charges in Michigan remain pending against Chin, who has pleaded not guilty and is serving a 10-1/2 year federal sentence.
Glenn Chin was the supervising pharmacist of the New England Compounding Center (NECC); an employee of Barry Cadden, the former President, who got a dime piece earlier this month:
Trial Date Set for Man Charged with Murder in Livingston County Fungal Meningitis Outbreak
By Danny Wimmer - May 20, 2024LANSING – Judge Matthew J. McGivney in the 44th Circuit Court in Livingston County set the trial for Glenn Chin, 56, of Canton, Massachusetts, for November 4, 2024. Chin faces 11 counts of second-degree murder for his alleged involvement in the deadly 2012 fungal meningitis outbreak.
“Eleven Michiganders tragically lost their lives as a result of a lack of concern for patient safety,” Nessel said. “My department looks forward to finally seeking justice for the victims and their families in court.”
Chin was the supervising pharmacist at the New England Compounding Center (NECC) in Framingham, Massachusetts. In 2012, a nationwide fungal meningitis outbreak resulted in 64 deaths, 11 of which occurred at the Michigan Pain Specialists Clinic (MPS) in Livingston County. Patients at the clinic were given epidural injections of the steroid methylprednisolone, which was compounded and produced at the NECC in Massachusetts and shipped to MPS. Donna Kruzich, Paula Brent, Lyn Laperriere, Mary Plettl, Gayle Gipson, Patricia Malafouris, Emma Todd, Jennie Barth, Ruth Madouse, Salley Roe, and Karina Baxter died as a result of being injected with the contaminated drug.
The Department alleges that Chin disregarded sterility procedures in the compounding of sterile medications, created fraudulent cleaning records, and falsified scientific testing results.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
Friends of MHF
Kirsten DeVries
Tom & Karen Nunheimer
Steve Ahonen
Ron & Faith Bosserman
Marlin & Kathy Klumpp
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
